LT - COMBINATION OF T-CELL CHECKPOINT INHIBITORS WITH INHIBITORS OF E-SELECTIN OR CXCR4, OR WITH HETEROBIFUNCTIONAL INHIBITORS OF BOTH E-SELECTIN AND CXCR4.
EN - COMBINATION OF T-CELL CHECKPOINT INHIBITORS WITH INHIBITORS OF E-SELECTIN OR CXCR4, OR WITH HETEROBIFUNCTIONAL INHIBITORS OF BOTH E-SELECTIN AND CXCR4.
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
Bibliografiniai duomenys
Tarptautinės patentų klasifikacijos indeksai (TPK)
| (51) |
INT.CL. |
C07K 16/28 |
(2006.01) |
|
|
C07K 16/2818 |
(2013.01) |
|
|
A61K 31/7034 |
(2006.01) |
|
|
A61K2039/505 |
(2013.01) |
|
|
A61K 39/00 |
(2006.01) |
|
|
C07K2317/76 |
(2013.01) |
|
|
A61K 31/7034 |
(2013.01) |
|
|
A61P 35/00 |
(2018.01) |
|
|
A61K 31/197 |
(2013.01) |
|
|
A61K 31/395 |
(2013.01) |
|
|
A61K 31/69 |
(2013.01) |
|
|
A61K 31/702 |
(2013.01) |
|
|
A61K 31/7068 |
(2013.01) |
Europos patentas
| (11) |
Patento numeris |
3497131 |
| (13) |
Dokumento rūšis |
T |
| (96) |
Europos patento paraiškos numeris |
17755592.7 |
|
Europos patento paraiškos padavimo data |
2017-08-07 |
| (97) |
Europos patento paraiškos paskelbimo data |
2019-06-19 |
| (45) |
Paskelbimo apie Europos patento išdavimą data |
2022-03-09
|
| (46) |
Apibrėžties vertimo paskelbimo data |
|
Tarptautinės paraiškos padavimo
| (86) |
Numeris |
PCT/US2017/045690 |
|
Data |
2017-08-07 |
Tarptautinės paraiškos paskelbimo
| (87) |
Numeris |
WO 2018/031445 |
|
Data |
2018-02-15 |
Prioriteto paraiškos
| (30) |
Numeris |
Data |
Šalis |
|
201662372116 P |
2016-08-08
|
US |
|
201662417045 P |
2016-11-03
|
US |
|
201662418722 P |
2016-11-07
|
US |
Išradėjai
| (72) |
MAGNANI, John L. , US
FOGLER, William E. , US
|
Savininkas
| (73) |
GlycoMimetics, Inc. ,
9708 Medical Center Drive, Rockville, MD 20850,
US
|
Pavadinimas
| (54) |
COMBINATION OF T-CELL CHECKPOINT INHIBITORS WITH INHIBITORS OF E-SELECTIN OR CXCR4, OR WITH HETEROBIFUNCTIONAL INHIBITORS OF BOTH E-SELECTIN AND CXCR4. |
| |
COMBINATION OF T-CELL CHECKPOINT INHIBITORS WITH INHIBITORS OF E-SELECTIN OR CXCR4, OR WITH HETEROBIFUNCTIONAL INHIBITORS OF BOTH E-SELECTIN AND CXCR4. |
